CAC
SRNE

Certified Advisory Corp’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Certified Advisory Corp’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,000
Closed -$10K – 850
2019
Q4 		$10K Buy
3,000
+2,900
+2,900% +$6.91K ﹤0.01% 592
2019
Q3 		$0 Buy
+100
New +$233 ﹤0.01% 842

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Certified Advisory Corp's SRNE Position: Q1 2020 in Review

Certified Advisory Corp sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2020, closing a stake of 3,000 shares — an estimated $10K sold.

Certified Advisory Corp first reported a position in SRNE in Q3 2019 and held it in 2 quarters. The position peaked at $10K in Q4 2019. 92 funds tracked by Wall St. Rank hold SRNE as of Q1 2020.

  • Certified Advisory Corp reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Certified Advisory Corp sold 3,000 Sorrento Therapeutics, Inc. shares in Q1 2020, an estimated $10K.
  • Certified Advisory Corp first reported a position in Sorrento Therapeutics, Inc. in Q3 2019 and held it in 2 quarters.
  • Certified Advisory Corp's Sorrento Therapeutics, Inc. position peaked at $10K in Q4 2019.
  • 92 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2020.

Based on Certified Advisory Corp's 13F filing for Q1 2020, filed 27 Apr 2020.